Patents Assigned to Novira Therapeutics, INC.
  • Derivatives and methods of treating hepatitis B infections
    Patent number: 10077264
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: September 18, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Derivatives and methods of treating hepatitis B infections
    Patent number: 9890161
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: February 13, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Azocane and azonane derivatives and methods of treating hepatitis B infections
    Patent number: 9884831
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: February 6, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9873671
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: January 23, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Pyridyl reverse sulfonamides for HBV treatment
    Patent number: 9765050
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: September 19, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: Ryan C. Clark, Yen Truong, Nicholas Stock, Jason Jacintho
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9758489
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: September 12, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventor: George D. Hartman
  • Hepatitis B antiviral agents
    Patent number: 9751857
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: September 5, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Osvaldo A. Flores
  • Hepatitis B antiviral agents
    Patent number: 9676747
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: June 13, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Osvaldo A. Flores
  • Sulfide alkyl compounds for HBV treatment
    Patent number: 9597332
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: March 21, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: Austin Chen, Yalda Bravo, Nicholas Stock, Bijan Pedram, Jason Jacintho, Ryan C. Clark
  • Hepatitis B antiviral agents
    Patent number: 9579313
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in man.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: February 28, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventor: George D. Hartman
  • Derivatives and methods of treating hepatitis B infections
    Patent number: 9550779
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: January 24, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Derivatives and methods of treating hepatitis B infections
    Patent number: 9527845
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: December 27, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Derivatives and methods of treating hepatitis B infections
    Patent number: 9518057
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: December 13, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9505722
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: November 29, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Piperidine derivatives and methods of treating hepatitis B infections
    Patent number: 9400280
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: July 26, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventor: George D. Hartman
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9339510
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: May 17, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Hepatitis B antiviral agents
    Patent number: 9205079
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in man.
    Type: Grant
    Filed: March 9, 2015
    Date of Patent: December 8, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventor: George D. Hartman
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9181288
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: November 10, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventors: George D. Hartman, Scott Kuduk
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9169212
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: October 27, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventors: George D. Hartman, Scott Kuduk
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9115113
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: August 25, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventor: George D Hartman